XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Net patient revenues $ 361,607,000 $ 285,823,000
Other revenues 12,090,000 11,353,000
Net operating revenues 373,697,000 297,176,000
Costs and expenses:    
Salaries, wages, and benefits 228,130,000 183,138,000
Other operating 92,457,000 77,429,000
Facility rent 11,365,000 10,348,000
Depreciation and amortization 10,978,000 10,586,000
Total costs and expenses 342,930,000 281,501,000
Income from operations 30,767,000 15,675,000
Other income (expense):    
Non–operating income 4,079,000 5,685,000
Interest expense (2,106,000) (46,000)
Unrealized gains on marketable equity securities 10,982,000 14,399,000
Income before income taxes 43,722,000 35,713,000
Income tax provision (11,432,000) (9,462,000)
Net income 32,290,000 26,251,000
Net income attributable to noncontrolling interest (85,000) (38,000)
Net income attributable to National HealthCare Corporation $ 32,205,000 $ 26,213,000
Earnings per share attributable to National HealthCare Corporation stockholders:    
Basic (in dollars per share) $ 2.09 $ 1.71
Diluted (in dollars per share) $ 2.07 $ 1.69
Weighted average common shares outstanding:    
Basic (in shares) 15,438,306 15,350,240
Diluted (in shares) 15,575,752 15,505,096